Remove digital how-natural-language-processing-can-make-difference-pharma
article thumbnail

Hollywood and the Metaverse’s effect on pharma’s content

pharmaphorum

Gaurav Kapoor, co-founder and executive vice president of Indegene, tells pharmaphorum how pharma can take lessons from the entertainment industry and prepare for the Metaverse to enhance content engagement. Pharma companies’ customer communication methods require reimagining as technology progresses.

article thumbnail

Deep Dive: Market Access

pharmaphorum

Not only has COVID forced companies, governments and healthcare systems to work towards approving drugs and vaccines in record times, the sector is also facing an influx of digital therapeutics and advanced drugs that don’t fit neatly into existing access frameworks. A long way to go” for digital health reimbursement.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Use of Artificial Intelligence in the Pharmaceutical Industry

Viseven

From the early beginning of the world’s digitalization, the mainstream media taught us that artificial intelligence is a super complicated mechanism that is supposed to cover human existence hurdles, explain the universe’s secrets, start or prevent a global cataclysm, and other significant events. Manufacturing process.

article thumbnail

Rare diseases, repurposing and the role of AI

pharmaphorum

Findacure’s Rick Thompson looks at how these technologies could bring us closer to treatments for underserved rare diseases. By definition, however, trial master files represent a much richer and more detailed source of data on a drug and how it performs. In the age of artificial intelligence, no trial data should be going to waste.

article thumbnail

Ep. 003 – Ritesh Patel Podcast Transcript

Pharma Marketing Network

RJ Lewis (EHS): Hello, this is RJ Lewis from Pharma Marketing Network. He’s the Chief Digital Officer for Health at Ogilvy. And he’s also a Pharma Marketing Network Editorial Advisory Board member. So tell me about the latest happenings that you’re seeing in the world of healthcare and digital innovation.

article thumbnail

Ep. 006 – Mark Stinson & Bob Baurys Podcast Transcript

Pharma Marketing Network

Don (PMN): Hi good morning everyone, welcome to the pharma marketing podcast. I come to the pharma space from being a medical operator of clinics for the last 15 to 20 years where we took care of patients with specific disease conditions that were often overlooked. Bob and Mark thanks for joining us today. Mark (83Bar): Yea thank you.

article thumbnail

Ep. 003 – Ritesh Patel Podcast Transcript

Pharma Marketing Network

RJ Lewis (EHS): Hello, this is RJ Lewis from Pharma Marketing Network. He’s the Chief Digital Officer for Health at Ogilvy. And he’s also a Pharma Marketing Network Editorial Advisory Board member. So tell me about the latest happenings that you’re seeing in the world of healthcare and digital innovation.